Clene Inc. Stock News

UBS cut the price target on Domino's Pizza, Inc. (NYSE: DPZ) from $430 to $385. Domino's shares rose 4% to $329.11 on Tuesday. Raymond James boosted the price target for The Progressive Corporation

Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Monday after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite climbing around 270 points on Monday. The Dow traded up 2.93% to 29,566.07 while the NASDAQ rose 2.56% to 10,846.26. The

Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) gained 641% to $2.0207 after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share. FedNat Holding Com

U.S. stocks extended gains midway through trading, with the Dow Jones gaining more than 600 points on Monday. The Dow traded up 2.17% to 29,349.33 while the NASDAQ rose 1.72% to 10,757.76. The S&P 500

Hot penny stocks to watch for October. The post Cheap Stocks To Buy Now? Hot Penny Stocks To Watch In October appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Conference Call and Webcast Set for 8:30 a.m. EDT Conference Call and Webcast Set for 8:30 a.m. EDT

Hot penny stocks to watch for October. The post Cheap Stocks To Buy Now?

Conference Call and Webcast Set for 8:30 a.m. EDT Conference Call and Webcast Set for 8:30 a.m. EDT

SALT LAKE CITY, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biop

SALT LAKE CITY, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Clene Inc.  (NASDAQ: CLNN) along with its subsidiaries “Clene” and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biophar

Clene Inc. (CLNN) delivered earnings and revenue surprises of -4.76% and 46.15%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

SALT LAKE CITY, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage bioph

SALT LAKE CITY, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage bioph

Gainers Plus Therapeutics, Inc. (NASDAQ: PSTV) shares rose 31.2% to $0.6931 in pre-market trading as the company presented positive data from ongoing ReSPECT™ clinical trials at the Annual Confere